Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Miroslav Myslivecek"'
Autor:
Jaroslav Bacovsky, Miroslav Myslivecek, Jiri Minarik, Vlastimil Scudla, Tomas Pika, Jana Zapletalova, Pavla Petrova, Margita Bartkova, Tomas Adam, Simon J Gronowitz
Publikováno v:
Biomedical Papers, Vol 159, Iss 1, Pp 135-138 (2015)
Aims: The study aimed at comparing two methods for evaluating thymidinekinase TK in serum - an older RIA method and novel DiviTum™ - in patients with MM and MGUS, and also comparing them with biochemical markers and degree of activity evaluated by
Externí odkaz:
https://doaj.org/article/89f87c66559846cca7f1113e162e1b95
Autor:
Miroslav Myslivecek, Jaroslav Bacovsky, Tomas Pika, Jana Zapletalová, Pavla Petrova, Tomáš Adam, Margita Bartkova, Simon J Gronowitz, Jiri Minarik, Vlastimil Scudla
Publikováno v:
Biomedical Papers, Vol 159, Iss 1, Pp 135-138 (2015)
Aims: The study aimed at comparing two methods for evaluating thymidinekinase TK in serum - an older RIA method and novel DiviTum™ - in patients with MM and MGUS, and also comparing them with biochemical markers and degree of activity evaluated by
Autor:
Tomas Papajik, Vít Procházka, Lenka Henzlová, Miroslav Myslivecek, Peter Turcsanyi, Marie Jarošová, Renata Urbanova, Patrik Flodr, Zuzana Kapitáňová, Eva Buriánková, Radim Formánek, Karel Indrak
Publikováno v:
Leukemia & Lymphoma. 55:314-319
The significance of positron emission tomography/computed tomography (PET/CT) in chronic lymphocytic leukemia (CLL) has not yet been systematically studied. This prospective study was aimed at assessing the benefit of PET/CT in patients with newly di
Autor:
Jana Zapletalová, Katherine Vomackova, Radim Formánek, Miroslav Myslivecek, Jan Cincibuch, Radek Vrba, Pavel Koranda, Čestmír Neoral
Publikováno v:
Biomedical Papers. 156:171-179
Aim: To evaluate the ability of hybrid 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) to predict histopathological response and overall survival (OS) after preoperative neoadjuvant chemoradiotherapy (CRT) in
Autor:
Miroslav Myslivecek, Martin Penicka, Milos Bilwachs, Milan Kamínek, Otto Lang, Helena Trojanova, Ivana Kunikova, Helena Balon
Publikováno v:
Clinical Nuclear Medicine. 36:762-766
PURPOSE Proper identification of the cardiac cycle is essential for gated SPECT myocardial perfusion imaging. We have developed an alternate method of ECG for gating, that is, using the peripheral pulse wave (PW) as the triggering signal for gated SP
Autor:
Zuzana Kubová, Miroslava Palová, Patrik Flodr, Miroslav Myslivecek, Ladislava Kucerova, Tomas Papajik, Ladislav Dušek, Karel Indrak, Eva Buriánková, Vít Procházka, Pavel Koranda, Luděk Raida, Jiří Jarkovský, Zuzana Šedová
Publikováno v:
European Journal of Haematology. 86:32-37
Objectives: Positron emission tomography using 2-[fluorine-18]-fluoro-2-deoxy-D-glucose (18F-FDG) is considered to be the most beneficial imaging method for staging patients with non-Hodgkin’s lymphoma (NHL). The intensity of 18F-FDG accumulation m
Autor:
Jana Zapletalová, Vlastimil Scudla, Tomas Pika, Miroslav Myslivecek, Eva Buriánková, Jaroslav Bacovsky, Pavel Koranda, Jiri Minarik
Publikováno v:
Clinical Nuclear Medicine. 35:667-670
PURPOSE: Technetium-99m 2 methoxyisobutylisonitrile (Tc-99m MIBI) scintigraphy has been used to identify biologic activity and extent of multiple myeloma (MM) and monoclonal gammopathy of unknown significance (MGUS). The examination could also serve
Publikováno v:
European Journal of Radiology. 64:432-438
Introduction Detection of residual disease following the completion of primary treatment in Hodgkin's lymphoma (HL) patients diagnosed with mediastinal tumor mass has an exceptional importance in the assessment of therapeutic response. Magnetic reson
Autor:
Zuzana Kubová, Vít Procházka, Jaroslava Drymlova, Tomas Papajik, Karel Indrak, Eva Buriánková, Ludek Raida, Miroslav Myslivecek, Ladislava Kucerova
Publikováno v:
Biomedical Papers. 151:109-112
BACKGROUND Monoclonal antibodies have dramatically changed the treatment possibilities for follicular lymphoma. (90)Y-ibritumomab tiuxetan (Zevalin) is the first radioimmunotherapy agent approved for the treatment of relapsed and resistant follicular
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging. 30:321-324
Radionuclide myocardial perfusion imaging (MPI) has been on the rise in Europe and the USA. Details on nuclear cardiology in the Czech Republic are not available as yet, as it is impossible to obtain comprehensive data from official registers owing t